Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Syndax Pharmaceuticals Inc
1T3Current price
15.5 EUR
0 EUR (0.00%)
Last closed
16.79 USD
Company
www.syndax.com
ISIN
US87164F1057
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
1 861 651 328 USD
Yield for 12 month
+6.89 %
1Y
3Y
5Y
10Y
15Y
1T3
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are revumenib, a potent, selective, small molecule inhibitor of the menin-MLL binding interaction for the treatment of KMT2A rearranged, acute leukemias, and solid tumor; and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD) and idiopathic pulmonary fibrosis (IPF). The company is also developing Entinostat. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts. Address: 35 Gatehouse Drive, Waltham, MA, United States, 02451
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
36.08 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+126 576 000 USD
Current Quarter
+12 500 000 USD
Last Quarter
+3 500 000 USD
Current Year
-12 000 USD
Last Year
-454 000 USD
Current Quarter
+12 498 000 USD
Last Quarter
-40 837 000 USD
Key Figures 1T3
1 year
3 years
5 years
10 years
EBITDA
-321 200 992 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-48.67 %
PEG Ratio
–
Return On Equity TTM
-81.88 %
Wall Street Target Price
36.08 USD
Revenue TTM
16 000 000 USD
Book Value
4.28 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
33297.4 %
Dividend Yield
–
Gross Profit TTM
139 709 000 USD
Earnings per share
-3.64 USD
Diluted Eps TTM
-3.64 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 1T3
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 1T3
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 1T3
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
91.0069
Price Sales TTM
116.3532
Enterprise Value EBITDA
-105.2642
Price Book MRQ
5.0805
Financials 1T3
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 1T3
For 52 weeks
14.5 USD
25.34 USD
50 Day MA
19.11 USD
Shares Short Prior Month
10 081 997
200 Day MA
20.99 USD
Short Ratio
10.6
Shares Short
10 510 079
Short Percent
12.45 %
BeatStart